HR 4866 · 116th Congress · Health
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020
Bill Progress
✓
Introduced✓
Committee✓
House Vote4
Senate5
EnactedLatest: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2020-09-22)
Plain Language Summary
[AI summary unavailable — showing source text]
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 4866, National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020
Nov 24, 2020As passed by the House of Representatives on September 21, 2020
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office
Cosponsors (2)
1 Democrat1 Republican